04/30/2025
CASTR Alliance Inc. is actively recruiting canine patients diagnosed with hemangiosarcoma of the spleen to participate in a clinical trial evaluating Paccal Vet chemotherapy at sites in Oregon, Washington, Southern California and Colorado. For more information see the AVMA Clinical Trials Database:
Hemangiosarcoma (HSA) is a highly aggressive and malignant vascular tumor occurring most commonly in dogs. Dogs with splenic hemangiosarcoma have a poor prognosis, with fewer than 20% of dogs surviving 9 months with surgery and adjuvant doxorubicin chemotherapy. Paclitaxel is one of the most effe...